{"id":"https://openalex.org/W1601052014","doi":null,"title":"Cyclodextrins and their Pharmaceutical Applications","display_name":"Cyclodextrins and their Pharmaceutical Applications","publication_year":2014,"publication_date":"2014-07-01","ids":{"openalex":"https://openalex.org/W1601052014","mag":"1601052014"},"language":"en","primary_location":{"id":"mag:1601052014","doi":null,"is_oa":false,"landing_page_url":"https://www.pharmatutor.org/pdf_download/pdf/Vol.%202,%20Issue%207,%20July%202014,%20PharmaTutor,%20Paper-3.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210228990","display_name":"Pharmatutor","issn_l":"2347-7881","issn":["2347-7881","2394-6679"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Pharmatutor","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022392144","display_name":"Abdulrhman Ahmed Akasha","orcid":"https://orcid.org/0009-0003-1692-6457","observed_orcids":["https://orcid.org/0009-0003-1692-6457"]},"institutions":[{"id":"https://openalex.org/I23906160","display_name":"University of Tripoli","ror":"https://ror.org/00taa2s29","country_code":"LY","type":"education","lineage":["https://openalex.org/I23906160"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Abdulrhman Ahmed Akasha","raw_affiliation_strings":["Tripoli University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tripoli University","institution_ids":["https://openalex.org/I23906160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077519255","display_name":"Malak Ali Elwahedi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I23906160","display_name":"University of Tripoli","ror":"https://ror.org/00taa2s29","country_code":"LY","type":"education","lineage":["https://openalex.org/I23906160"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Malak Ali Elwahedi","raw_affiliation_strings":["Tripoli University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tripoli University","institution_ids":["https://openalex.org/I23906160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076290546","display_name":"Areej Mohmoud Eldeeb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I23906160","display_name":"University of Tripoli","ror":"https://ror.org/00taa2s29","country_code":"LY","type":"education","lineage":["https://openalex.org/I23906160"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Areej Mohmoud Eldeeb","raw_affiliation_strings":["Tripoli University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tripoli University","institution_ids":["https://openalex.org/I23906160"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I23906160"],"apc_list":null,"apc_paid":null,"fwci":0.425,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.55175931,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"2","issue":"7","first_page":"40","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10578","display_name":"Supramolecular Chemistry and Complexes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclodextrins","display_name":"cyclodextrins","score":1.0},{"id":"https://openalex.org/keywords/inclusion-complexes","display_name":"inclusion complexes","score":0.9160000085830688},{"id":"https://openalex.org/keywords/beta-cyclodextrin","display_name":"\u03b2-cyclodextrin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/drug-solubility-enhancement","display_name":"drug solubility enhancement","score":0.6000000238418579},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7919999957084656},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.8730000257492065},{"id":"https://openalex.org/keywords/moisture-stability","display_name":"humidity stability","score":0.5799999833106995},{"id":"https://openalex.org/keywords/direct-compression","display_name":"direct compression","score":0.515999972820282},{"id":"https://openalex.org/keywords/taste-masking","display_name":"taste masking","score":0.597000002861023},{"id":"https://openalex.org/keywords/phenytoin-sodium","display_name":"phenytoin sodium","score":0.8410000205039978},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9200000166893005},{"id":"https://openalex.org/keywords/piroxicam","display_name":"piroxicam","score":0.9829999804496765},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.7170000076293945},{"id":"https://openalex.org/keywords/oral-formulations","display_name":"oral dosage forms","score":0.35899999737739563}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.797074556350708},{"id":"https://openalex.org/C2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","level":2,"score":0.7244006395339966},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.723491907119751},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.6335358023643494},{"id":"https://openalex.org/C2778649806","wikidata":"https://www.wikidata.org/wiki/Q261310","display_name":"Inclusion compound","level":3,"score":0.5595342516899109},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.48616692423820496},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.4560752213001251},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44802531599998474},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.4414488971233368},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3751552700996399},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3619365394115448},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.11472952365875244},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.11248224973678589},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1601052014","doi":null,"is_oa":false,"landing_page_url":"https://www.pharmatutor.org/pdf_download/pdf/Vol.%202,%20Issue%207,%20July%202014,%20PharmaTutor,%20Paper-3.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210228990","display_name":"Pharmatutor","issn_l":"2347-7881","issn":["2347-7881","2394-6679"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Pharmatutor","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1972653036","https://openalex.org/W2064113715","https://openalex.org/W2130784669"],"related_works":["https://openalex.org/W2411711440","https://openalex.org/W3080439620","https://openalex.org/W4388576198","https://openalex.org/W2951635483","https://openalex.org/W2042373769","https://openalex.org/W2315679909","https://openalex.org/W989567047","https://openalex.org/W2107001533","https://openalex.org/W2739910051","https://openalex.org/W2194085886"],"abstract_inverted_index":{"Cyclodextrins":[0,15],"are":[1,16,83,141,200],"formed":[2],"by":[3,27,66,145],"the":[4,11,49,72,94,107,131,164,193,211],"action":[5],"of":[6,48,52,64,89,96,109,118,152,177,206,213],"cyclodextrin-trans-glycosidase":[7],"enzyme":[8],"(CTG)":[9],"on":[10],"medium":[12],"containing":[13,19],"starch.":[14],"cyclic":[17],"oligosaccharides":[18],"at":[20],"least":[21],"six":[22],"D-(+)-":[23],"glucopyranose":[24],"units":[25],"attached":[26],"\u03b1":[28,36],"(1-4)":[29],"glucoside":[30],"bonds.":[31],"The":[32,103,116,150],"three":[33],"natural":[34],"cyclodextrins,":[35],",":[37],"\u03b2":[38],"and":[39,46,136,169,188],"\u03b3":[40],"differ":[41],"in":[42,86,113,126,159,203],"their":[43,55,68],"ring":[44],"size":[45],"solubility.One":[47],"striking":[50],"feature":[51],"cyclodextrins":[53,110],"is":[54,182],"ability":[56],"to":[57,92,129,162,209],"form":[58],"inclusion":[59,124,157,180],"complexes":[60,112,181],"with":[61],"a":[62,78,127,160,183],"variety":[63],"compounds,":[65],"entrapping":[67],"molecules":[69],"(guest)":[70],"inside":[71],"cyclodextrin":[73],"cavity,":[74],"which":[75,140],"act":[76],"as":[77,197],"host.":[79],"Cyclodextrin":[80],"complexing":[81,198],"agent":[82],"often":[84,201],"used,":[85],"pharmaceutical":[87,114,204],"formulation":[88,205],"oral":[90,207],"products,":[91],"increase":[93,210],"bioavailability":[95,212],"poorly":[97,214],"water":[98,215],"soluble":[99,216],"or":[100,217],"unstable":[101,218],"drug.":[102],"simplified":[104],"review":[105],"presents":[106],"evaluation":[108],"drug":[111,132,165],"formulation.":[115],"preparation":[117,151,176],"sodium":[119,154],"valproate":[120],"phenytoin":[121,153],"sodium/":[122],"\u03b2-cyclodextrin":[123,156,179],"complex":[125,158],"trial":[128,161],"stabilize":[130,163],"against":[133,166],"moisture":[134,167],"absorption":[135,168,189],"forming":[137],"non-hygroscopic":[138],"powders":[139],"suitable":[142],"for":[143],"tablets":[144],"direct":[146],"compression":[147],"was":[148,174],"reviewed.":[149],"/":[155],"mask":[170],"its":[171],"bitter":[172],"taste":[173],"reviewed.The":[175],"piroxicam/":[178],"exhibited":[184],"higher":[185],"dissolution":[186],"rates":[187],"efficiency":[190],"values,":[191],"than":[192],"corresponding":[194],"un-complexes":[195],"drug.Cyclodextrins":[196],"agents":[199],"used":[202],"products":[208],"drugs.":[219]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2016-06-24T00:00:00"}